Global, regional, and national burden of inflammatory bowel disease and its associated anemia, 1990 to 2019 and predictions to 2050: An analysis of the global burden of disease study 2019
- PMID: 38052263
- DOI: 10.1016/j.autrev.2023.103498
Global, regional, and national burden of inflammatory bowel disease and its associated anemia, 1990 to 2019 and predictions to 2050: An analysis of the global burden of disease study 2019
Abstract
Aim: Inflammatory bowel disease (IBD) exhibited a global increase in incidence over the past decade. Understanding global burden of IBD can offer valuable insights for shaping future management strategies. We aimed to provide a comprehensive assessment of global burden of IBD from 1990 to 2019 and predictions to 2050.
Methods: Data on prevalence, incidence, Disability-Adjusted Life Years (DALYs), Years Lived with Disability (YLDs) and IBD-attributable impairment factor (anemia) were extracted from the Global Burden of Diseases (GBD) 2019. Subgroup analyses were performed based on gender, geographical regions, and the Socio-Demographic Index (SDI). Joinpoint model, Bayesian age-period-cohort model and decomposition methodology were utilized to evaluate the temporal trends from 1990 to 2019, forecast the disease burden up to 2050 and decompose incidence, prevalence, YLDs and DALYs of IBD by population age structure, population growth and epidemiologic changes.
Results: From 1990 to 2019, number of prevalence, DALYs, YLDs for IBD and number of prevalence for IBD-related-anemia increased significantly. Age-standardized rates of incidence, prevalence, DALYs, and YLDs showed declining trends, with this decline anticipated to continue until 2050 for both genders. The IBD burden remained high in countries with high and high-middle SDI. Besides, countries with low, low-middle, and middle SDI were experiencing an increasing burden. Number and ASR of prevalence and YLDs of IBD related anemia increased with SDI Decomposition analysis indicated that population growth was the primary contributing factor, followed by population aging.
Conclusion: Due to population growth and aging, the burden of IBD is projected to continue rising until 2050, which emphasizes the urgency of addressing the evolving public health challenge posed by IBD.
Keywords: Anemia; Epidemiology; Global burden of disease; Inflammatory bowel disease; Prediction.
Copyright © 2023 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.Lancet Gastroenterol Hepatol. 2020 Jan;5(1):17-30. doi: 10.1016/S2468-1253(19)30333-4. Epub 2019 Oct 21. Lancet Gastroenterol Hepatol. 2020. PMID: 31648971 Free PMC article.
-
Trends and projections of inflammatory bowel disease at the global, regional and national levels, 1990-2050: a bayesian age-period-cohort modeling study.BMC Public Health. 2023 Dec 14;23(1):2507. doi: 10.1186/s12889-023-17431-8. BMC Public Health. 2023. PMID: 38097968 Free PMC article.
-
Global burden of inflammatory bowel disease 1990-2019: A systematic examination of the disease burden and twenty-year forecast.World J Gastroenterol. 2023 Nov 14;29(42):5751-5767. doi: 10.3748/wjg.v29.i42.5751. World J Gastroenterol. 2023. PMID: 38075848 Free PMC article.
-
Analysis of global prevalence, DALY and trends of inflammatory bowel disease and their correlations with sociodemographic index: Data from 1990 to 2019.Autoimmun Rev. 2024 Nov;23(11):103655. doi: 10.1016/j.autrev.2024.103655. Epub 2024 Oct 2. Autoimmun Rev. 2024. PMID: 39366514 Review.
-
Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019.BMJ Open. 2023 Mar 28;13(3):e065186. doi: 10.1136/bmjopen-2022-065186. BMJ Open. 2023. PMID: 36977543 Free PMC article. Review.
Cited by
-
Mechanism of Action and Therapeutic Implications of Nrf2/HO-1 in Inflammatory Bowel Disease.Antioxidants (Basel). 2024 Aug 20;13(8):1012. doi: 10.3390/antiox13081012. Antioxidants (Basel). 2024. PMID: 39199256 Free PMC article. Review.
-
Emerging role of small RNAs in inflammatory bowel disease and associated colorectal cancer (Review).Int J Mol Med. 2025 Feb;55(2):33. doi: 10.3892/ijmm.2024.5474. Epub 2024 Dec 20. Int J Mol Med. 2025. PMID: 39704210 Free PMC article. Review.
-
PANoptosis in intestinal epithelium: its significance in inflammatory bowel disease and a potential novel therapeutic target for natural products.Front Immunol. 2025 Jan 7;15:1507065. doi: 10.3389/fimmu.2024.1507065. eCollection 2024. Front Immunol. 2025. PMID: 39840043 Free PMC article. Review.
-
Global burden and cross-national inequalities of tobacco-attributable cancers in adults aged 40 and above, 1990-2021: a population-based study.Front Oncol. 2025 Jul 25;15:1631356. doi: 10.3389/fonc.2025.1631356. eCollection 2025. Front Oncol. 2025. PMID: 40786509 Free PMC article.
-
The global burden of heart failure attributable to interstitial lung diseases: insights from the global burden of disease study 2021.BMC Cardiovasc Disord. 2025 Apr 7;25(1):262. doi: 10.1186/s12872-025-04702-y. BMC Cardiovasc Disord. 2025. PMID: 40189529 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous